AZD-9291 dimesylate

CAS No. ——

AZD-9291 dimesylate( Osimertinib dimesylate | Mereletinib dimesylate )

Catalog No. M16969 CAS No. ——

A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AZD-9291 dimesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.
  • Description
    A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively; weak activity against wt EGFR (IC50=184 nM); inhibits signaling pathways and cellular growth in both EGFRm(+) and EGFRm(+)/T790M(+) mutant cell lines in vitro; exhibits tumor regression in EGFR-mutant tumor xenograft and transgenic models; orally active.Lung Cancer Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Osimertinib dimesylate | Mereletinib dimesylate
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    691.8187
  • Molecular Formula
    C30H41N7O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 0.4 mg/mL
  • SMILES
    ——
  • Chemical Name
    2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:2)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Finlay MR, et al. J Med Chem. 2014 Oct 23;57(20):8249-67. 2. Cross DA, et al. Cancer Discov. 2014 Sep;4(9):1046-61. 3. Eberlein CA, et al. Cancer Res. 2015 Jun 15;75(12):2489-500.
molnova catalog
related products
  • OBX02-011

    OBX02-011 is an effective and reversible inhibitor of EGFR tyrosine kinase with IC50s of 0.134 and 2.09 nM for triple mutants Del19/T790M/C797S and L858R/T790M/C797S.

  • Cimigenoside

    Cimigenoside is an active compound from genus Cimicifuga.

  • SKLB 1028

    SKLB 1028 (Ruserontinib) is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. SKLB 1028 shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.